IGF2BP3 and urinary bladder carcinoma: Results of qRT-PCR and immunoblotting analysis displayed elevated mRNA and protein levels of IGF2BP3 in the tumor tissues of 30 bladder cancer patients than the matched adjacent non-tumor bladder tissues (Fig. 5B, C).